DAVID POPLACK to Dose-Response Relationship, Drug
This is a "connection" page, showing publications DAVID POPLACK has written about Dose-Response Relationship, Drug.
Connection Strength
0.190
-
Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Cancer Chemother Pharmacol. 2000; 45(3):259-64.
Score: 0.032
-
Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells. Biochem Pharmacol. 1993 Nov 02; 46(9):1627-36.
Score: 0.021
-
Variability in the oral bioavailability of all-trans-retinoic acid. J Natl Cancer Inst. 1993 Jun 16; 85(12):993-6.
Score: 0.020
-
Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts. Biochem Pharmacol. 1993 Apr 06; 45(7):1493-501.
Score: 0.020
-
Dose-dependent pharmacokinetics of all-trans-retinoic acid. J Natl Cancer Inst. 1992 Sep 02; 84(17):1332-5.
Score: 0.019
-
Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine. Cancer Res. 1992 Jun 15; 52(12):3503-5.
Score: 0.019
-
Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine. Cancer Res. 1986 Dec; 46(12 Pt 1):6286-9.
Score: 0.013
-
Experimental approaches to the treatment of CNS leukemia. Am J Pediatr Hematol Oncol. 1979; 1(2):141-9.
Score: 0.007
-
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Clin Cancer Res. 1998 Feb; 4(2):357-60.
Score: 0.007
-
Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. J Clin Oncol. 1995 May; 13(5):1238-41.
Score: 0.006
-
Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression. J Immunother (1991). 1992 Feb; 11(2):111-8.
Score: 0.005
-
Phase I/pharmacokinetic reevaluation of thioTEPA. Cancer Res. 1991 Jun 15; 51(12):3171-6.
Score: 0.004
-
Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients. Cancer Res. 1990 Nov 15; 50(22):7226-31.
Score: 0.004
-
Transient acute hepatotoxicity of high-dose methotrexate therapy during childhood. NCI Monogr. 1987; (5):207-12.
Score: 0.003
-
Probenecid inhibition of methotrexate cytotoxicity in mouse L1210 leukemia cells. Cancer Treat Rep. 1984 Mar; 68(3):521-5.
Score: 0.003
-
Inhibition of human lymphoproliferation by intravenous lipid emulsion. Clin Immunol Immunopathol. 1982 Nov; 25(2):196-202.
Score: 0.002
-
"Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood. 1978 May; 51(5):835-42.
Score: 0.002
-
Effect of Corynebacterium parvum, methanol-extraction residue of BCG, and levamisole on macrophage random migration, chemotaxis, and pinocytosis. J Natl Cancer Inst. 1977 Jun; 58(6):1753-7.
Score: 0.002